• Something wrong with this record ?

Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators

T. David, V. Hlinová, V. Kubíček, R. Bergmann, F. Striese, N. Berndt, D. Szöllősi, T. Kovács, D. Máthé, M. Bachmann, HJ. Pietzsch, P. Hermann,

. 2018 ; 61 (19) : 8774-8796. [pub] 20180924

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19045259

Bifunctional derivatives of bis(phosphinate)-bearing cyclam (BPC) chelators bearing a carboxylate, amine, isothiocyanate, azide, or cyclooctyne in the BP side chain were synthesized. Conjugations required no protection of phosphinate or ring secondary amine groups. The ring amines were not reactive (proton protected) at pH < ∼8. For isothiocyanate coupling, oligopeptide N-terminal α-amines were more suitable than alkyl amines, e.g., Lys ω-amine (p Ka ∼7.5-8.5 and ∼10-11, respectively) due to lower basicity. The Cu-64 labeling was efficient at room temperature (specific activity ∼100 GBq/μmol; 25 °C, pH 6.2, ∼100 ligand equiv, 10 min). A representative Cu-64-BPC was tested in vivo showing fast clearance and no nonspecific radioactivity deposition. The monoclonal anti-PSCA antibody 7F5 conjugates with thiocyanate BPC derivative or NODAGA were radiolabeled and studied in PC3-PSCA tumor bearing mice by PET. The radiolabeled BPC conjugate was accumulated in the prostate tumor with a low off-target uptake, unlike Cu-64-labeled NODAGA-antibody conjugate. The BPC chelators have a great potential for theranostic applications of the Cu-64/Cu-67 matched pair.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045259
003      
CZ-PrNML
005      
20200113081951.0
007      
ta
008      
200109s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.jmedchem.8b00932 $2 doi
035    __
$a (PubMed)30180567
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a David, Tomáš $u Department of Inorganic Chemistry, Faculty of Science , Charles University , Hlavova 2030 , 128 40 Prague , Czech Republic. Institute of Radiopharmaceutical Cancer Research , Helmholtz-Zentrum Dresden-Rossendorf , Bautzner Landstrasse 400 , 01328 Dresden , Germany.
245    10
$a Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators / $c T. David, V. Hlinová, V. Kubíček, R. Bergmann, F. Striese, N. Berndt, D. Szöllősi, T. Kovács, D. Máthé, M. Bachmann, HJ. Pietzsch, P. Hermann,
520    9_
$a Bifunctional derivatives of bis(phosphinate)-bearing cyclam (BPC) chelators bearing a carboxylate, amine, isothiocyanate, azide, or cyclooctyne in the BP side chain were synthesized. Conjugations required no protection of phosphinate or ring secondary amine groups. The ring amines were not reactive (proton protected) at pH < ∼8. For isothiocyanate coupling, oligopeptide N-terminal α-amines were more suitable than alkyl amines, e.g., Lys ω-amine (p Ka ∼7.5-8.5 and ∼10-11, respectively) due to lower basicity. The Cu-64 labeling was efficient at room temperature (specific activity ∼100 GBq/μmol; 25 °C, pH 6.2, ∼100 ligand equiv, 10 min). A representative Cu-64-BPC was tested in vivo showing fast clearance and no nonspecific radioactivity deposition. The monoclonal anti-PSCA antibody 7F5 conjugates with thiocyanate BPC derivative or NODAGA were radiolabeled and studied in PC3-PSCA tumor bearing mice by PET. The radiolabeled BPC conjugate was accumulated in the prostate tumor with a low off-target uptake, unlike Cu-64-labeled NODAGA-antibody conjugate. The BPC chelators have a great potential for theranostic applications of the Cu-64/Cu-67 matched pair.
650    _2
$a zvířata $7 D000818
650    _2
$a monoklonální protilátky $x chemie $x farmakokinetika $7 D000911
650    _2
$a chelátory $x chemie $x farmakokinetika $7 D002614
650    _2
$a radioizotopy mědi $x chemie $x farmakokinetika $7 D003301
650    _2
$a stabilita léku $7 D004355
650    _2
$a imunokonjugáty $x chemie $x farmakokinetika $7 D018796
650    _2
$a izotopové značení $7 D007553
650    _2
$a makrocyklické laktamy $x chemie $x farmakokinetika $7 D047029
650    _2
$a ligandy $7 D008024
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a kyseliny fosfinové $x chemie $7 D010721
650    _2
$a pozitronová emisní tomografie $7 D049268
650    _2
$a nádory prostaty $x diagnóza $x diagnostické zobrazování $x metabolismus $7 D011471
650    _2
$a radiofarmaka $x chemie $x farmakokinetika $7 D019275
650    _2
$a potkani nazí $7 D011923
650    _2
$a potkani Wistar $7 D017208
650    _2
$a tkáňová distribuce $7 D014018
650    _2
$a nádorové buňky kultivované $7 D014407
650    _2
$a xenogenní modely - testy protinádorové aktivity $7 D023041
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hlinová, Veronika $u Department of Inorganic Chemistry, Faculty of Science , Charles University , Hlavova 2030 , 128 40 Prague , Czech Republic.
700    1_
$a Kubíček, Vojtěch $u Department of Inorganic Chemistry, Faculty of Science , Charles University , Hlavova 2030 , 128 40 Prague , Czech Republic.
700    1_
$a Bergmann, Ralf $u Institute of Radiopharmaceutical Cancer Research , Helmholtz-Zentrum Dresden-Rossendorf , Bautzner Landstrasse 400 , 01328 Dresden , Germany.
700    1_
$a Striese, Franziska $u Institute of Radiopharmaceutical Cancer Research , Helmholtz-Zentrum Dresden-Rossendorf , Bautzner Landstrasse 400 , 01328 Dresden , Germany.
700    1_
$a Berndt, Nicole $u Partner Site Dresden , German Cancer Consortium (DKTK) , Fetscherstrasse 74 , 01307 Dresden , Germany. German Cancer Research Center (DKFZ) , Im Neuenheimer Feld 280 , 69120 Heidelberg , Germany.
700    1_
$a Szöllősi, Dávid $u Department of Biophysics and Radiation Biology , Semmelweis University , Tűzoltó utca 37-47 , H-1094 Budapest , Hungary.
700    1_
$a Kovács, Tibor $u Institute of Radiochemistry and Radioecology , University of Pannonia , Egyetem St. 10 , H-8200 Veszprém , Hungary. Social Organization for Radioecological Cleanliness , P.O. Box 158, H-8200 Veszprém , Hungary.
700    1_
$a Máthé, Domokos $u Department of Biophysics and Radiation Biology , Semmelweis University , Tűzoltó utca 37-47 , H-1094 Budapest , Hungary.
700    1_
$a Bachmann, Michael $u Institute of Radiopharmaceutical Cancer Research , Helmholtz-Zentrum Dresden-Rossendorf , Bautzner Landstrasse 400 , 01328 Dresden , Germany. Tumor Immunology, University Cancer Center (UCC) , "Carl Gustav Carus" Technische Universität Dresden , Fetscherstrasse 74 , 01307 Dresden , Germany. National Center for Tumor Diseases (NCT) , "Carl Gustav Carus" Technische Universität Dresden , Fetscherstrasse 74 , 01307 Dresden , Germany.
700    1_
$a Pietzsch, Hans-Jürgen $u Institute of Radiopharmaceutical Cancer Research , Helmholtz-Zentrum Dresden-Rossendorf , Bautzner Landstrasse 400 , 01328 Dresden , Germany.
700    1_
$a Hermann, Petr $u Department of Inorganic Chemistry, Faculty of Science , Charles University , Hlavova 2030 , 128 40 Prague , Czech Republic.
773    0_
$w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 61, č. 19 (2018), s. 8774-8796
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30180567 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113082322 $b ABA008
999    __
$a ok $b bmc $g 1483528 $s 1083932
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 61 $c 19 $d 8774-8796 $e 20180924 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
LZP    __
$a Pubmed-20200109

Find record

Citation metrics

Archiving options